000 01344 a2200385 4500
005 20250512031642.0
264 0 _c19861009
008 198610s 0 0 eng d
022 _a0012-186X
024 7 _a10.1007/BF00506530
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLager, I
245 0 0 _aStudies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors.
_h[electronic resource]
260 _bDiabetologia
_cJul 1986
300 _a409-16 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCatecholamines
_xpharmacology
650 0 4 _aFatty Acids, Nonesterified
_xblood
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInsulin
_xmetabolism
650 0 4 _aInsulin Antagonists
650 0 4 _aMale
650 0 4 _aMetoprolol
_xblood
650 0 4 _aPropranolol
_xblood
650 0 4 _aReceptors, Adrenergic, beta
_xdrug effects
700 1 _aAttvall, S
700 1 _aEriksson, B M
700 1 _avon Schenk, H
700 1 _aSmith, U
773 0 _tDiabetologia
_gvol. 29
_gno. 7
_gp. 409-16
856 4 0 _uhttps://doi.org/10.1007/BF00506530
_zAvailable from publisher's website
999 _c3023614
_d3023614